Search Results - "PARP inhibitor"

Suggested Topics within your search.
Refine Results
  1. 41
    Cover Image

    Taking the next step in PARP-inhibitor clinical trials in older women with ovarian cancer - Staging the aging by G. Liposits, S.M. Lichtman

    Published 2021
    Connect to this object online.
    Book

    Save to List
    Saved in:
  2. 42
    Cover Image

    Risk of severe hematologic toxicities in cancer patients treated with PARP inhibitors: results of monotherapy and combination therapy trials by Alecu I, Milenkova T, Turner SR

    Published 2018
    Connect to this object online.
    Book

    Save to List
    Saved in:
  3. 43
    Cover Image

    Evaluation of the Efficacy of PARP Inhibitors in Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis by Kan Wu, Jiayu Liang, Yanxiang Shao, Sanchao Xiong, Shuyang Feng, Xiang Li

    Published 2021
    Connect to this object online.
    Book

    Save to List
    Saved in:
  4. 44
    Cover Image

    PARP inhibitor era in ovarian cancer treatment: a systematic review and meta-analysis of randomized controlled trials by István Baradács, Brigitta Teutsch, Alex Váradi, Alexandra Bilá, Ádám Vincze, Péter Hegyi, Tamás Fazekas, Balázs Komoróczy, Péter Nyirády, Nándor Ács, Ferenc Bánhidy, Balázs Lintner

    Published 2024
    Connect to this object online.
    Book

    Save to List
    Saved in:
  5. 45
    Cover Image

    Auranofin Synergizes with the PARP Inhibitor Olaparib to Induce ROS-Mediated Cell Death in Mutant p53 Cancers by Laurie Freire Boullosa, Jinthe Van Loenhout, Tal Flieswasser, Christophe Hermans, Céline Merlin, Ho Wa Lau, Elly Marcq, Marlies Verschuuren, Winnok H. De Vos, Filip Lardon, Evelien L. J. Smits, Christophe Deben

    Published 2023
    Connect to this object online.
    Book

    Save to List
    Saved in:
  6. 46
    Cover Image

    DNA repair biomarkers to guide usage of combined PARP inhibitors and chemotherapy: A meta-analysis and systematic review by Zoe Phan, Caroline E. Ford, C. Elizabeth Caldon

    Published 2023
    Connect to this object online.
    Book

    Save to List
    Saved in:
  7. 47
    Cover Image

    Combination of erlotinib and a PARP inhibitor inhibits growth of A2780 tumor xenografts due to increased autophagy by Sui H, Shi C, Yan Z, Li H

    Published 2015
    Connect to this object online.
    Book

    Save to List
    Saved in:
  8. 48
    Cover Image

    Baseline risk of hematologic malignancy at initiation of frontline PARP inhibitor maintenance for BRCA1/2-associated ovarian cancer by Anastasia Navitski, Duaa H. Al-Rawi, Ying Liu, Maria M. Rubinstein, Claire F. Friedman, Raajit K. Rampal, Diana L. Mandelker, Karen Cadoo, Roisin E. O'Cearbhaill

    Published 2021
    Connect to this object online.
    Book

    Save to List
    Saved in:
  9. 49
    Cover Image

    Causes of resistance to PARP inhibitors and ways to overcome it. Case report of aggressive <i>BRCA</i>-related breast cancer by A. I. Stukan, A. Yu. Goryainova, S. V. Sharov, O. A. Goncharova, Z. K. Khachmamuk, V. V. Durov

    Published 2022
    Connect to this object online.
    Book

    Save to List
    Saved in:
  10. 50
    Cover Image

    Natural pentacyclic triterpenoid from Pristimerin sensitizes p53-deficient tumor to PARP inhibitor by ubiquitination of Chk1 by Li Tao, Xiangyu Xia, Shujing Kong, Tingye Wang, Fangtian Fan, Weimin Wang

    Published 2024
    Connect to this object online.
    Book

    Save to List
    Saved in:
  11. 51
    Cover Image

    Tumor burden is a potential marker of PARP inhibitor effects in ovarian cancer: a head-to-head observational series by Jing Ni, Rui Zhou, Xianzhong Cheng, Xia Xu, Wenwen Guo, Xiaoxiang Chen

    Published 2020
    Connect to this object online.
    Book

    Save to List
    Saved in:
  12. 52
    Cover Image

    Poly ADP-ribose polymerase (PARP) inhibitors - new therapeutic strategies in Acute Myeloid Leukemia: a literature review by Emilia Nowicka, Michał Obel, Kinga Panuciak, Angelika Mastalerczyk, Kamila Czyżak, Jan Lejman, Karolina Makowska, Wiktor Wiśniewski

    Published 2022
    Connect to this object online.
    Book

    Save to List
    Saved in:
  13. 53
    Cover Image

    Risk of severe hematologic toxicities in cancer patients treated with PARP inhibitors: a meta-analysis of randomized controlled trials by Zhou JX, Feng LJ, Zhang X

    Published 2017
    Connect to this object online.
    Book

    Save to List
    Saved in:
  14. 54
    Cover Image

    Layer‐by‐layer nanoparticles for novel delivery of cisplatin and PARP inhibitors for platinum‐based drug resistance therapy in ovarian cancer by Lawrence B. Mensah, Stephen W. Morton, Jiahe Li, Haihua Xiao, Mohiuddin A. Quadir, Kevin M. Elias, Emily Penn, Aysen K. Richson, Paiman Peter Ghoroghchian, Joyce Liu, Paula T. Hammond

    Published 2019
    Connect to this object online.
    Book

    Save to List
    Saved in:
  15. 55
    Cover Image

    Inhibiting PARP as a Strategic Target in Cancer by Kristin Zorn

    Published 2016
    Subjects: “…PARP inhibitor…”
    DOAB: download the publication
    DOAB: description of the publication
    Electronic Book Chapter

    Save to List
    Saved in:
  16. 56
    Cover Image

    Recurrence rate in early-stage epithelial ovarian cancer: Is there a role for upfront maintenance with PARP inhibitors in stages I and II? by Monica D. Levine, David M. O'Malley, Paulina J. Haight, Leigha Senter, Vincent Wagner, Kristin L. Bixel, David E. Cohn, Larry J. Copeland, Casey M. Cosgrove, Eric M. McLaughlin, Floor J. Backes

    Published 2023
    Connect to this object online.
    Book

    Save to List
    Saved in:
  17. 57
    Cover Image

    Rucaparib for PARP inhibitor-pretreated ovarian cancer: A GEICO retrospective subgroup analysis from the Spanish Rucaparib Access Program by Alfonso Yubero, Purificación Estévez, Aránzazu Barquín, Luisa Sánchez, Ana Santaballa, Bella Pajares, Piedad Reche, Carmen Salvador, Luis Manso, Raúl Márquez, Antonio González-Martín

    Published 2023
    Connect to this object online.
    Book

    Save to List
    Saved in:
  18. 58
    Cover Image

    Efficacy and safety of PARP inhibitors for maintenance treatment of ovarian cancer, regardless of BRCA or HRD status: a comprehensive updated meta-analysis by Yanhui Li

    Published 2023
    Connect to this object online.
    Book

    Save to List
    Saved in:
  19. 59
    Cover Image

    Efficacy and safety of PARP inhibitor maintenance therapy for ovarian cancer: a meta-analysis and trial sequential analysis of randomized controlled trials by Guojuan Sun, Yi Liu

    Published 2024
    Connect to this object online.
    Book

    Save to List
    Saved in:
  20. 60
    Cover Image

    Regulatory histories of recently withdrawn ovarian cancer treatment indications of 3 PARP inhibitors in the US and Europe: lessons for the accelerated approval pathway by Mahnum Shahzad, Huseyin Naci, Katharine M. Esselen, Joseph A. Dottino, Anita K. Wagner

    Published 2024
    Connect to this object online.
    Book

    Save to List
    Saved in:

Search Tools: